InfuSystem Holdings Appoints New Directors, Updates Executive Contracts

Ticker: INFU · Form: 8-K · Filed: Nov 18, 2024 · CIK: 1337013

Infusystem Holdings, INC 8-K Filing Summary
FieldDetail
CompanyInfusystem Holdings, INC (INFU)
Form Type8-K
Filed DateNov 18, 2024
Risk Levelmedium
Pages3
Reading Time3 min
Sentimentneutral

Sentiment: neutral

Topics: board-changes, executive-compensation, governance

TL;DR

InfuSystem adds two directors and updates CEO/CFO contracts.

AI Summary

InfuSystem Holdings, Inc. announced on November 12, 2024, changes in its board of directors and executive compensation. Specifically, the company elected two new directors, Michael J. O'Malley and David A. Smith, to its Board. Additionally, the company entered into new employment agreements with its Chief Executive Officer, Steven R. Johnson, and Chief Financial Officer, Jonathan P. Rose.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Changes in board and executive roles can introduce uncertainty regarding future strategy and operational direction.

Key Players & Entities

FAQ

Who were the newly elected directors for InfuSystem Holdings, Inc.?

Michael J. O'Malley and David A. Smith were elected as new directors.

What is the date of the earliest event reported in this 8-K filing?

The earliest event reported is dated November 12, 2024.

What specific items are being reported in this Form 8-K?

The filing reports on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.

What is the principal business address of InfuSystem Holdings, Inc.?

The principal business address is 3851 West Hamlin Road, Rochester Hills, Michigan 48309.

What are the former names of InfuSystem Holdings, Inc.?

The company was formerly known as HAPC, Inc. and Healthcare Acquisition Partners Corp.

Filing Stats: 824 words · 3 min read · ~3 pages · Grade level 11.4 · Accepted 2024-11-18 09:15:26

Filing Documents

01 - Financial Statements and Exhibits

Item 9.01 - Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release of InfuSystem Holdings, Inc. dated November 18 , 202 4 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INFUSYSTEM HOLDINGS, INC. By: /s/ Barry Steele Barry Steele Chief Financial Officer Dated: November 18, 2024

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing